TY - JOUR
T1 - Recent advances in nano and micro formulations of Ginsenoside to enhance their therapeutic efficacy
AU - Sana, Siva Sankar
AU - Chandel, Arvind K. Singh
AU - Raorane, Chaitany Jayprakash
AU - Saad, Mohamed Aly Aly
AU - Kim, Seong-Cheol
AU - Raj, Vinit
AU - Lee, Sangkil
N1 - Publisher Copyright:
© 2024 Elsevier GmbH
PY - 2024/11
Y1 - 2024/11
N2 - Background and Aims: Ginsenosides, the main component of Panax ginseng, have long been recognized for their therapeutic benefits and are thought to have neuroprotective, antidiabetic, anti-depressant, antioxidant, anti-cancer, and anti-stress properties. However, due to their low water solubility, low biomembrane permeability, gastrointestinal dysfunction, and total metabolism in the body, ginsenosides have a poor absorption profile that has hindered the therapeutic potential of these organic molecules. Methods: Initially, we broadly illuminated the several techniques of extraction of Ginsenosides using Panax quinquefolius and Panax ginseng. Subsequently, we focused on different delivery methods to improve the stability, permeability, and solubility of natural chemicals, which raises the bioavailability of ginsenoside. Lastly, we explained significance of a variety of nano and microscale delivery systems, including liposomes, ethosomes, transfersomes, metal/metal oxide systems, micro/nanoemulsions, polymeric micro/nanoparticles (NPs), liposomes, transfersomes, and micelles to increase the bioavailability of ginsenosides. Results: The utilization of micro/nanoscale delivery methods, such as liposome-based delivery, polymer micro/nanoparticle distribution, and micro/nanoemulsion, to increase the bioavailability of ginsenosides has recently advanced, and we have emphasized these advances in this study. Furthermore, the disadvantages of ginsenosides were also discussed, including the challenges associated with putting these delivery systems into practice in clinical settings and suggestions for further research. Conclusion: In summary, ginsenosides-based administration has several benefits that make it a potentially useful substance for a range of therapeutic purposes.
AB - Background and Aims: Ginsenosides, the main component of Panax ginseng, have long been recognized for their therapeutic benefits and are thought to have neuroprotective, antidiabetic, anti-depressant, antioxidant, anti-cancer, and anti-stress properties. However, due to their low water solubility, low biomembrane permeability, gastrointestinal dysfunction, and total metabolism in the body, ginsenosides have a poor absorption profile that has hindered the therapeutic potential of these organic molecules. Methods: Initially, we broadly illuminated the several techniques of extraction of Ginsenosides using Panax quinquefolius and Panax ginseng. Subsequently, we focused on different delivery methods to improve the stability, permeability, and solubility of natural chemicals, which raises the bioavailability of ginsenoside. Lastly, we explained significance of a variety of nano and microscale delivery systems, including liposomes, ethosomes, transfersomes, metal/metal oxide systems, micro/nanoemulsions, polymeric micro/nanoparticles (NPs), liposomes, transfersomes, and micelles to increase the bioavailability of ginsenosides. Results: The utilization of micro/nanoscale delivery methods, such as liposome-based delivery, polymer micro/nanoparticle distribution, and micro/nanoemulsion, to increase the bioavailability of ginsenosides has recently advanced, and we have emphasized these advances in this study. Furthermore, the disadvantages of ginsenosides were also discussed, including the challenges associated with putting these delivery systems into practice in clinical settings and suggestions for further research. Conclusion: In summary, ginsenosides-based administration has several benefits that make it a potentially useful substance for a range of therapeutic purposes.
KW - Drug delivery
KW - Ginsenoside
KW - Nanoparticles
KW - Panax ginseng
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pureapplicaion&SrcAuth=WosAPI&KeyUT=WOS:001316404900001&DestLinkType=FullRecord&DestApp=WOS_CPL
U2 - 10.1016/j.phymed.2024.156007
DO - 10.1016/j.phymed.2024.156007
M3 - Review article
C2 - 39276537
SN - 0944-7113
VL - 134
JO - Phytomedicine
JF - Phytomedicine
M1 - 156007
ER -